Alere executives filed a complaint in Delaware Chancery Court Aug. 26 alleging Abbott failed to obtain the necessary U.S. antitrust approvals for the merger.
In March, Alere disclosed the Justice Department had subpoenaed documents from the company to investigate Alere’s overseas business practices.
Alere has since disclosed a separate U.S. investigation into billing practices at a Texas-based laboratory., according to the article.
Despite Alere’s legal troubles, Abbott said in a statement that the company remains committed to the acquisition.
More articles on legal and regulatory issues:
Michigan health department appeals secret court order
Illinois OKs EMTs to use syringe over EpiPen
SC Supreme court declines to rule on Greenville Health System’s switch to partially private hospital
